Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.10.14
Canaccord Genuity Maintains Buy on BioNTech, Lowers Price Target to $132
Benzinga
2026.10.14
CDT Equity Announces Patent Filing From Sarborg Limited For Its Intellectual Property Covering Novel Solid Forms Of Respiratory Medicine
Benzinga
2026.10.14
Canaccord Genuity Initiates Coverage On Seaport Therapeutics with Buy Rating, Announces Price Target of $28
Benzinga
2026.10.14
BlackRock CEO Larry Fink Says Competition For Capital Is Growing; At This Moment, We're Going To Have Structurally Higher Interest Rates For Longer
Benzinga
2026.10.14
'Oman, Russia And China Mediating Ceasefire Talks With Houthis, Official Says' - Associated Press
Benzinga
2026.10.14
Susquehanna Maintains Neutral on Stem, Lowers Price Target to $4.5
Benzinga
2026.10.14
Virgin Galactic Inks 24-Month Agreement With Space Warfare Directorate Over Use Of Virgin Galactic's Spaceship
Benzinga
2026.10.14
Susquehanna Maintains Neutral on SolarEdge Technologies, Lowers Price Target to $32
Benzinga
2026.10.14
Susquehanna Maintains Positive on Sunrun, Lowers Price Target to $13
Benzinga
2026.10.14
Susquehanna Maintains Neutral on Plug Power, Lowers Price Target to $1.75
Benzinga
2026.10.14
MaxCyte Reports Preliminary Q3 Core Revenue Of ~$8.1M, Up 26% YoY; Raises FY26 Revenue Guidance To ~$34M, Core Business Revenue Outlook To ~$28M
Benzinga
2026.10.14
Meta, JPMorgan, West Pharmaceutical And More: CNBC’s ‘Final Trades’
Benzinga
2026.10.14
Susquehanna Maintains Positive on Nextpower, Lowers Price Target to $150
Benzinga
2026.10.14
Canaccord Genuity Initiates Coverage On Amprius Technologies with Buy Rating, Announces Price Target of $14
Benzinga
2026.10.14
Evolution Metals & Technologies Reaffirms FY27 Sales Guidance Of $400M-$460M; Expects To Begin Acquiring Equipment To Produce Samarium Cobalt Magnets By Mid-2027; Confirms Will Respond To U.S. Army’s Sources Sought Notice For Rare Earth Magnets
Benzinga
2026.10.14
Atara Biotherapeutics' Partner Pierre Fabre Pharmaceuticals Receives FDA Acceptance To Refile Biologics License Application For Tabelecleucel To Treat Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease
Benzinga
2026.10.14
Daxor Announces New Clinical Studies Validate BVA Technology In High-Acuity Heart Failure Populations To Enhance Care At HFSA 2026 Annual Scientific Meeting
Benzinga
2026.10.14
Susquehanna Maintains Positive on GE Vernova, Lowers Price Target to $1270
Benzinga
2026.10.14
AEP Plans $4B Investment In 702-MW Wyoming Fuel Cell Project Under 20-Year Power Deal With Google
Benzinga
2026.10.14
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
Benzinga
2026.10.14
12 Industrials Stocks Moving In Wednesday's Pre-Market Session
Benzinga
2026.10.14
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Benzinga
2026.10.14
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga
2026.10.14
Sensata Technologies Announces Its Brake Force Sensors Now Enable Electromechanical Braking Systems In Electric Vehicles
Benzinga
2026.10.14
Strive Exercises $369.2M Warrants From Oct. 12 Through Oct. 13
Benzinga
2026.10.14
Susquehanna Maintains Positive on Fluence Energy, Lowers Price Target to $13
Benzinga
2026.10.14
Datacentrex Begins Installation And Energization Of Acquisition Of More Than 500 Additional ElphaPex DG2 Scrypt ASIC Miners; Expects To Increase Online Scrypt Hashrate By ~21%
Benzinga
2026.10.14
Susquehanna Maintains Neutral on Enphase Energy, Lowers Price Target to $35
Benzinga
2026.10.14
Niki BioSolutions' DiamiR Biosciences Subsidiary To Perform Apolipoprotein E Genotyping On Plasma Samples From Global Alzheimer’s Platform Foundation Bio-Hermes-002 Trial Group
Benzinga
2026.10.14
Fusion Fuel Green H1 EPS $(1.35), Sales $7.598M
Benzinga
1
...
764
765
766
767
768
769
770
771
>